LOX-1 Inhibition in ApoE KO Mice Using a Schizophyllan-based Antisense Oligonucleotide Therapy.
about
LOX-1 and Its Splice Variants: A New Challenge for Atherosclerosis and Cancer-Targeted Therapies.The lectin-like oxidized low-density lipoprotein receptor-1 as therapeutic target for atherosclerosis, inflammatory conditions and longevity.LOX-1, OxLDL, and atherosclerosisThe role of lectin-like oxidised low-density lipoprotein receptor-1 in vascular pathology.Chronic Aerobic Exercise Decreases Lectin-Like Low Density Lipoprotein (LOX-1) Receptor Expression in Heart of Diabetic Rat.Clinical analysis of lectin-like oxidized low-density lipoprotein receptor-1 in patients with in-stent restenosis after percutaneous coronary intervention.
P2860
LOX-1 Inhibition in ApoE KO Mice Using a Schizophyllan-based Antisense Oligonucleotide Therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
LOX-1 Inhibition in ApoE KO Mi ...... sense Oligonucleotide Therapy.
@en
LOX-1 Inhibition in ApoE KO Mi ...... sense Oligonucleotide Therapy.
@nl
type
label
LOX-1 Inhibition in ApoE KO Mi ...... sense Oligonucleotide Therapy.
@en
LOX-1 Inhibition in ApoE KO Mi ...... sense Oligonucleotide Therapy.
@nl
prefLabel
LOX-1 Inhibition in ApoE KO Mi ...... sense Oligonucleotide Therapy.
@en
LOX-1 Inhibition in ApoE KO Mi ...... sense Oligonucleotide Therapy.
@nl
P2093
P2860
P50
P356
P1476
LOX-1 Inhibition in ApoE KO Mi ...... sense Oligonucleotide Therapy.
@en
P2093
Francesco Romeo
Hironori Ando
Laura Diano
Lucia Cutuli
Lucia Vecchione
Yoshikazu Koyama
P2860
P356
10.1038/MTNA.2012.45
P577
2012-12-04T00:00:00Z